Safety, Efficacy, and Pharmacokinetics Study of Tarceva to Treat Advanced Colorectal Cancer

NCT00047762 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Erlotinib (aka Tarceva or OSI-774)
DRUG: Bevacizumab (aka Avastin or Rhu MAb VEGF)

Sponsor

Genentech, Inc.